MaxCyte Partners with Prime Medicine to Advance Gene Editing Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...

August 02, 2023 | Wednesday | News
Melinta Therapeutics Announces Commercial Availability of REZZAYO™ (rezafungin for injection)

Melinta Therapeutics, LLC  announced the availability of REZZAYO™ (rezafungin for injection), for the treatment of candidemia and invasive candi...

August 01, 2023 | Tuesday | News
BioNTech Completes Acquisition of InstaDeep

Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design and development InstaDeep to opera...

August 01, 2023 | Tuesday | News
Sanofi Acquires Fast-Growing U.S. Brand Qunol® in Healthy Aging Segment.

Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...

July 31, 2023 | Monday | News
Hyro Partners with Gozio Health for AI-Powered Patient Communications

Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...

July 28, 2023 | Friday | News
Lupin Emphasizes In-Home Cardiovascular Care with Digital Therapeutics

India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...

July 25, 2023 | Tuesday | News
ImmunoGen Partners with ImmunoBiochem for Next-Gen Antibody-Drug Conjugates

Collaboration Combines ImmunoGen's Proprietary Linker-Payload Technology with Antibodies Developed by ImmunoBiochem Agreement Grants ImmunoGen an Exclusiv...

July 25, 2023 | Tuesday | News
Baxter Launches PERCLOT Absorbable Hemostatic Powder

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder ...

July 25, 2023 | Tuesday | News
Menarini Group Receives Positive CHMP Opinion for ORSERDU® in ER+ Metastatic Breast Cancer

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

July 24, 2023 | Monday | News
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility

Pfizer confirms all its colleagues are safe following a tornado that damaged predominantly the warehouse portion of its manufacturing facility in Rocky M...

July 24, 2023 | Monday | News
Tillotts Pharma and TVM Capital Form Mage Biologics to Develop Oral Antibody Therapy for Ulcerative Colitis

Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to ensure optimal and local trea...

July 21, 2023 | Friday | News
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States call...

July 21, 2023 | Friday | News
Massive Bio and CureMatch Partner to Revolutionize Cancer Treatment with AI and Clinical Trial Accessibility.

Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representa...

July 19, 2023 | Wednesday | News
HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia&...

July 19, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close